-+ 0.00%
-+ 0.00%
-+ 0.00%

Revolution Medicines files initial beneficial ownership statement; Chief Global Commercialization Officer Anthony Mancini reports 54,400 common shares

Reuters·03/26/2026 22:44:42

Please log in to view news